EUVIMEDEUVIMED entdecken
Open Access

Patients With IgA Vasculitis and Kawasaki Disease Show Dysregulated Interferon Signature

Sevki Erdem Varol, Cisem Cinar, Nihan Burtecene, Sezgin Sahin, Mehmet Yildiz, Kenan Barut, Haluk Cokugras, Sinem Firtina, Ozgur Kasapcopur iD, Ayca Kiykim iD

International Journal of Rheumatic Diseases · 2025

DOI: 10.1111/1756-185x.70349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Sevki Erdem Varol und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Mucocutaneous Lymph Node Syndrome, IgA Vasculitis, Immunoglobulin A, Interferon Type I. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Scientific Research Projects Coordination Unit of Istanbul University-Cerrahpasa, Turkish Pediatric Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

IgA vasculitis (IgAV) and Kawasaki disease (KD) are the most common forms of childhood vasculitis. Although various factors such as viral infections, genetic factors, and environmental factors are involved in the development of both diseases, their pathogenesis remains unclear. The interferon (IFN) signature, which reflects the activation of type I IFN signaling pathways, is a diagnostic and prognostic tool that contributes significantly to the pathogenesis and management of autoimmune diseases. In our study, we aimed to investigate the role of the IFN signature in patients with IgAV and KD. Material and Methods Thirty‐two children with IgAV and four patients diagnosed with KD were included in the study. Serum levels of IL‐1, IL‐6, IL‐8, IL‐10, IL‐17, IL‐18, TNF‐α, TNF‐R1, TNF‐R2, and IFN‐gamma were analyzed in the serum samples of all participants, and the expression of IFN‐related genes ( STAT1, IFI27, IFI44, IFI44L, IFIT1 , and RSAD2 ) was assessed in the patients and healthy controls ( n = 26) to calculate the IFN score by RT‐PCR method.

Results

A significant increase in the expression of three genes ( IFIT1, IFI44, and IFI27 ) and decreased expression of the other three genes ( RSAD2, STAT1 , and IFI44L ) was found in patients with IgAV and KD compared to the control group. Significantly higher IFN scores (IFN > 3) were found in patients with gastrointestinal involvement, in patients who required corticosteroid therapy, and in patients who had to be hospitalized. No significant difference in IFN levels was found between patients with and without renal involvement. Significantly higher serum IL‐1 levels were found in patients with gastrointestinal symptoms with IgAV. High IFN scores were found in three out of four patients diagnosed with KD.

Conclusion

A dysregulated type 1 IFN signature was found in patients with IgAV and KD compared to the control group. A significantly increased risk of gastrointestinal involvement required corticosteroid therapy, and hospitalization was observed in patients diagnosed with IgAV who had high IFN levels. This underlines the idea that the IFN score could serve as a crucial prognostic indicator.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucocutaneous Lymph Node SyndromeIgA VasculitisImmunoglobulin AInterferon Type IInterferonsHumansMaleFemaleChild, PreschoolChildSTAT1 Transcription FactorCase-Control StudiesAdaptor Proteins, Signal TransducingMembrane ProteinsBiomarkersSignal TransductionInfantCarrier ProteinsAntigensCytoskeletal ProteinsTumor Suppressor Proteins

Stichwörter der Autor:innen

Kawasaki diseasechildrenimmunoglobulin A vasculitisinterferon signature

Substanzen

STAT1 Transcription FactorSTAT1 protein, humanIFI44 protein, humanIFI44L protein, humanIFI27 protein, humanAdaptor Proteins, Signal TransducingMembrane ProteinsBiomarkersImmunoglobulin AInterferon Type I

Autor:innen und Institutionen

  • Department of Pediatrics, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Türkiye.
  • Department of Medical Genetics, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Türkiye.
  • Department of Pediatric Immunology and Allergy, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Türkiye.
  • Department of Pediatric Rheumatology, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Türkiye.

ORCID-Profile: Ozgur Kasapcopur, Ayca Kiykim

Förderung

  • Scientific Research Projects Coordination Unit of Istanbul University-Cerrahpasa
  • Turkish Pediatric Society

Zitieren

APA

Varol, S. E., Cinar, C., Burtecene, N., Sahin, S., Yildiz, M., Barut, K., Cokugras, H., Firtina, S., Kasapcopur, O., & Kiykim, A. (2025). Patients With IgA Vasculitis and Kawasaki Disease Show Dysregulated Interferon Signature. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70349

Vancouver

Varol SE, Cinar C, Burtecene N, Sahin S, Yildiz M, Barut K, et al. Patients With IgA Vasculitis and Kawasaki Disease Show Dysregulated Interferon Signature. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70349

BibTeX
@article{Varol2025,
  author = {Varol, Sevki Erdem and Cinar, Cisem and Burtecene, Nihan and Sahin, Sezgin and Yildiz, Mehmet and Barut, Kenan and Cokugras, Haluk and Firtina, Sinem and Kasapcopur, Ozgur and Kiykim, Ayca},
  title = {Patients With IgA Vasculitis and Kawasaki Disease Show Dysregulated Interferon Signature},
  journal = {International Journal of Rheumatic Diseases},
  year = {2025},
  doi = {10.1111/1756-185x.70349}
}
Kostenlos starten →